Concepedia
Statistics
Publications
13
Citations
2.1K
H-Index
11
Active since
2000
Affiliations
University of Nottingham(Current)
Bayer (United States)
Massachusetts General Hospital
Liverpool John Moores University
Harvard University
Christopher Carter is an author at University of Nottingham specializing in medicine, computing, and data ethics.
Publications per year
2000–2021
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
Li Liu, Yichen Cao, Charles Chen et al. · Cancer Research · 2006 · 1.5K citations · Full text
Medicine, Oncology, Pharmacology +17
Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair: A five-year experience
Richard P. Cambria, J.Kenneth Davison, Christopher Carter et al. · Journal of Vascular Surgery · 2000 · 175 citations
Medicine, Anesthesiology, Surgery +14
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo
Armen B. Shanafelt, Yue Lin, Marie-Claude Shanafelt et al. · Nature Biotechnology · 2000 · 133 citations
Life Sciences, Immunology, Oncology +14
Bridging social capital as a resource for rural revitalisation in China? A survey of community connection of university students with home villages
Bin Wu, Christopher Carter · Journal of Rural Studies · 2019 · 44 citations · Full text
Social Sciences, Higher Education, Sociology +17
Using <i>Second Life</i> in human resource development
Steph Broadribb, Christopher Carter · British Journal of Educational Technology · 2009 · 32 citations
Management, Human Resource Management, Organizational Development +10
1–5 of 13